Anthropic's closely matched Polymarket odds around $1–2 trillion valuations stem primarily from its May 2026 $65 billion Series H round that established a $965 billion private post-money valuation, surpassing OpenAI and reflecting explosive demand for its Claude large language model amid the AI arms race. Annualized revenue reached $47 billion at that time, with backers projecting $100–120 billion by year-end to support potentially record IPO pricing above $2 trillion in an October Nasdaq debut. Confidential S-1 filing in June, ongoing investor meetings, and rivalry with OpenAI heighten uncertainty over final multiples and timing, while any regulatory or market shifts could alter outcomes before the 2027 deadline.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-updateWhat will Anthropic's IPO valuation be?
What will Anthropic's IPO valuation be?
$1.25–$1.50T 51%
<$1.25T 48%
$1.50–$1.75T 48%
$1.75–$2.00T 46%
BAGO
BAGO
Dec 31, 2027
<$1.25T
48%
$1.25–$1.50T
51%
$1.50–$1.75T
48%
$1.75–$2.00T
46%
$2.00–$2.25T
13%
$2.25–$2.50T
11%
$2.50T+
9%
No IPO by December 31, 2027
6%
$1.25–$1.50T 51%
<$1.25T 48%
$1.50–$1.75T 48%
$1.75–$2.00T 46%
BAGO
BAGO
Dec 31, 2027
<$1.25T
$0 Vol.
48%
$1.25–$1.50T
$0 Vol.
51%
$1.50–$1.75T
$0 Vol.
48%
$1.75–$2.00T
$0 Vol.
46%
$2.00–$2.25T
$0 Vol.
13%
$2.25–$2.50T
$0 Vol.
11%
$2.50T+
$0 Vol.
9%
No IPO by December 31, 2027
$0 Vol.
6%
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.Anthropic's closely matched Polymarket odds around $1–2 trillion valuations stem primarily from its May 2026 $65 billion Series H round that established a $965 billion private post-money valuation, surpassing OpenAI and reflecting explosive demand for its Claude large language model amid the AI arms race. Annualized revenue reached $47 billion at that time, with backers projecting $100–120 billion by year-end to support potentially record IPO pricing above $2 trillion in an October Nasdaq debut. Confidential S-1 filing in June, ongoing investor meetings, and rivalry with OpenAI heighten uncertainty over final multiples and timing, while any regulatory or market shifts could alter outcomes before the 2027 deadline.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Binuksan ang Market: Aug 19, 2026, 9:45 AM ET
Volume
$0Petsa ng Pagtatapos
Dec 31, 2027Binuksan ang Market
Aug 19, 2026, 9:45 AM ETResolver
0x69c47De9D...This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.Anthropic's closely matched Polymarket odds around $1–2 trillion valuations stem primarily from its May 2026 $65 billion Series H round that established a $965 billion private post-money valuation, surpassing OpenAI and reflecting explosive demand for its Claude large language model amid the AI arms race. Annualized revenue reached $47 billion at that time, with backers projecting $100–120 billion by year-end to support potentially record IPO pricing above $2 trillion in an October Nasdaq debut. Confidential S-1 filing in June, ongoing investor meetings, and rivalry with OpenAI heighten uncertainty over final multiples and timing, while any regulatory or market shifts could alter outcomes before the 2027 deadline.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Volume
$0Petsa ng Pagtatapos
Dec 31, 2027Binuksan ang Market
Aug 19, 2026, 9:45 AM ETResolver
0x69c47De9D...Anthropic's closely matched Polymarket odds around $1–2 trillion valuations stem primarily from its May 2026 $65 billion Series H round that established a $965 billion private post-money valuation, surpassing OpenAI and reflecting explosive demand for its Claude large language model amid the AI arms race. Annualized revenue reached $47 billion at that time, with backers projecting $100–120 billion by year-end to support potentially record IPO pricing above $2 trillion in an October Nasdaq debut. Confidential S-1 filing in June, ongoing investor meetings, and rivalry with OpenAI heighten uncertainty over final multiples and timing, while any regulatory or market shifts could alter outcomes before the 2027 deadline.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update
Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong